Intraventricular Catheter System for IVH

Last updated: October 16, 2024
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stroke

Hemorrhage

Brain Injury

Treatment

IRRAflow® Active Fluid Exchange System

Traditional extraventricular drain

Non-contrast head CTs

Clinical Study ID

NCT05970549
STUDY-21-01815
  • Ages > 18
  • All Genders

Study Summary

The purpose of this research study is to evaluate the safety and outcomes associated with the use of IRRAflow® System catheters in externally draining intracranial fluid to reduce intracranial pressure. This study will be comparing the IRRAflow® system to standard of care catheters used in the same procedure. The IRRAflow® system is FDA approved for this procedure.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age >=18 years of age

  • Intraventricular hemorrhage documented on head CT or MRI scan

  • Need of cerebrospinal fluid drainage

  • Indication for active treatment evaluated by the treating physicians

  • Signed informed consent obtained by patient or Legal Authorized Representative

  • Treatment possible within 72 hours of ictus

Exclusion

Exclusion Criteria:

  • Patient has fixed and dilated pupils

  • Pregnant or nursing women (fertile female participants will be required to take avalidated pregnancy test for evaluation of pregnancy)

Study Design

Total Participants: 120
Treatment Group(s): 3
Primary Treatment: IRRAflow® Active Fluid Exchange System
Phase:
Study Start date:
June 14, 2022
Estimated Completion Date:
December 31, 2025

Study Description

Intracranial hemorrhagic conditions can rapidly cause brain damage and often considered life- threatening. Of these, Intracerebral hemorrhagic (ICH) is the most common type of hemorrhagic stroke and is associated with higher rates of morbidity and mortality than all stroke subtypes.

Management of hemorrhagic patients is typically orchestrated by neurosurgeons and neuro-intensivists. Comprehensive care should include surveillance and monitoring of Intra Cranial Pressure (ICP), Cerebral Perfusion Pressure (CPP), and hemodynamic function. Furthermore, prevention of infection, complications of immobility through positioning and mobilization within physiological tolerance play an important role in optimizing outcomes after ICH.

There are multiple approaches to facilitating Cerebrospinal Fluid (CSF) drainage and monitor ICP. Routinely, intracranial pressure is measured by use of devices inserted into the brain parenchyma or cerebral ventricles. A Ventricular Catheter (VC) inserted into the lateral ventricle allows for drainage of CSF to help reduce ICP. Although CSF drainage is a vital sequence in patient management, there are reported risks including infection and limitations related to erroneous readings associated with current ICP monitors. Physicians lack the appropriate tools to employ active intermittent aspiration and drainage with continuous ICP monitoring.

The current clinical study is being initiated to evaluate the hypothesis that active irrigation by IRRAflow will reduce the time needed for clearance of intraventricular blood from intraventricular space.

Connect with a study center

  • Icahn School of Medicine at Mount Sinai

    New York, New York 10128
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.